All products are 100% genuine and sourced from trusted manufacturers, with authenticity that can be verified for complete peace of mind.
Order exactly what you need with no minimum quantity required, whether itās a single unit or a larger order.
Your order is guaranteed to arrive safely, with full shipment tracking and dedicated support to ensure a smooth delivery experience.
Your payments are protected with industry-standard encryption and trusted payment providers, ensuring every transaction is safe, private, and secure.
For professional use only.
Manufacturer: Novo Nordisk
Active Substance(s): SEMAGLUTIDE
Strength: 1mg
Pack Size: 1 pen, 4 disposable NovoFineĀ® Plus needles (4 Doses)
Ozempic is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management.
-
Cold chain shipping available for temperature-sensitive products.
-
Orders are processed within 1ā2 business days.
-
Delivery timelines vary by destination and shipping method ā view our Shipping Policy for region-specific estimates.
-
Tracking information will be provided once shipped.
-
No order minimum applies.
-
If your shipment is delayed, lost, or arrives damaged, you're covered under our Refund & Replacement Policy.
We accept Visa, Mastercard, and American Express. Apple Pay and Google Pay are available upon request via your account manager.
All transactions are processed through a secure, PCI DSSācompliant system to ensure your data is fully protected.
Why Choose Medica Depot
Shop hundreds of medical products with no minimums and free shipping on large orders.
400+ products
No order minimums
Free shipping
Loyalty rewards
Trusted since 2007
Account manager
Verified LOT numbers
INFORMATION
OZEMPICĀ® 1mg: Key Features and Benefits
OZEMPICĀ® 1mg is an injectable medication that contains semaglutide, a GLP-1 receptor agonist, used to help manage blood sugar levels in patients with type 2 diabetes. It works by stimulating insulin release and reducing glucose production in the liver, leading to better control of blood sugar levels.
Key Features:
- Active Ingredient: Semaglutide.
- Available in multiple dosages: 0.25 mg, 0.5 mg, 1 mg, and 2 mg, administered once a week.
- Subcutaneous injection: Can be injected into the abdomen, thigh, or upper arm.
- Effective for glycemic control: Helps lower blood glucose and supports weight loss.
Benefits:
- Weight loss: Helps in losing weight, especially in patients struggling with obesity.
- Improved glycemic control: Significantly reduces blood glucose levels in people with type 2 diabetes.
- Can be used alone or in combination with other medications like insulin or metformin.
OZEMPICĀ® 1mg: Indications
OZEMPICĀ® is primarily indicated for patients with type 2 diabetes mellitus who require better control of blood glucose levels. It can also be used for patients with established cardiovascular disease to reduce the risk of major cardiovascular events.
Indications:
- Type 2 diabetes: Improves blood sugar levels when used alongside diet and exercise.
- Cardiovascular risk reduction: Reduces the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
OZEMPICĀ® 1mg: Ingredients
OZEMPICĀ® contains semaglutide as its active ingredient. The formulation also includes other components to stabilize and preserve the injection.
Ingredients:
- Semaglutide (active ingredient).
- Dibasic sodium phosphate dihydrate: Buffer.
- Phenol: Preservative.
- Propylene glycol: Stabilizer.
- Water for injections: Solvent.
OZEMPICĀ® 1mg: How To Use
OZEMPICĀ® is administered once a week, at any time of day, with or without meals. It should be injected subcutaneously into the abdomen, thigh, or upper arm. The starting dose is typically 0.25 mg for the first 4 weeks, followed by 0.5 mg per week. If needed, the dose can be increased to 1 mg or 2 mg.
Instructions for Use:
- Starting Dose: 0.25 mg once weekly for the first 4 weeks.
- Increase Dose: After 4 weeks, increase to 0.5 mg, then to 1 mg if necessary.
- Injection Sites: Administer the injection into the abdomen, thigh, or upper arm, rotating sites each week.
- Missed Dose: If a dose is missed, administer it within 5 days. If more than 5 days have passed, skip the missed dose and continue the regular schedule.
OZEMPICĀ® 1mg: Side Effects
Common side effects associated with OZEMPICĀ® are primarily gastrointestinal, such as nausea, vomiting, and diarrhea. Rare but serious side effects include pancreatitis, thyroid cancer, and kidney injury.
Common Side Effects:
- Nausea: Occurs in up to 20% of patients.
- Vomiting, diarrhea, and abdominal pain are also common.
- Decreased appetite and fatigue.
Serious Side Effects:
- Pancreatitis: Severe abdominal pain with nausea and vomiting.
- Thyroid C-cell tumors: Risk of medullary thyroid carcinoma (MTC) and other thyroid issues.
- Acute kidney injury: Particularly in patients with pre-existing kidney problems.
OZEMPICĀ® 1mg: Clinical Studies
Clinical trials have shown that OZEMPICĀ® is effective in reducing HbA1c and promoting weight loss in patients with type 2 diabetes. It also has cardiovascular benefits, helping reduce the risk of heart attacks, strokes, and cardiovascular deaths.
Key Findings:
- HbA1c Reduction: Significant decrease in HbA1c levels, with a reduction of up to 1.6% in patients using 1 mg of OZEMPICĀ®.
- Weight Loss: Patients lost between 2-5 kg depending on the dosage.
- Cardiovascular Outcomes: Patients with type 2 diabetes and heart disease had a 20-30% reduction in major cardiovascular events when treated with OZEMPICĀ®.
OZEMPICĀ® 1mg: Manufacturer Information
OZEMPICĀ® is manufactured by Novo Nordisk, a leading global pharmaceutical company specializing in diabetes care. Novo Nordisk is committed to providing innovative treatments for diabetes, obesity, and other chronic conditions.
Manufacturer Details:
- Brand: OZEMPICĀ®.
- Manufacturer: Novo Nordisk.
- Headquarters: Denmark.
- Specialization: Diabetes and obesity treatment.
OZEMPICĀ® 1mg: FAQ
How often should I inject OZEMPICĀ®?
OZEMPICĀ® is injected once a week, at the same time each week. It can be administered with or without food.
Can I use OZEMPICĀ® if I have type 1 diabetes?
No, OZEMPICĀ® is not for type 1 diabetes. It is specifically for type 2 diabetes mellitus.
What should I do if I miss a dose?
If you miss a dose, administer it within 5 days. If more than 5 days have passed, skip the dose and continue with your regular schedule.
Are there any risks associated with using OZEMPICĀ®?
Yes, some serious risks include pancreatitis, thyroid tumors, and kidney injury. Gastrointestinal side effects like nausea and vomiting are also common.
Can OZEMPICĀ® be used during pregnancy? OZEMPICĀ® is not recommended during pregnancy.
If you plan to become pregnant, discontinue OZEMPICĀ® at least 2 months before pregnancy. Always consult your doctor before making changes to your medication during pregnancy.
OZEMPICĀ® 1mg: Key Features and Benefits
OZEMPICĀ® 1mg is an injectable medication that contains semaglutide, a GLP-1 receptor agonist, used to help manage blood sugar levels in patients with type 2 diabetes. It works by stimulating insulin release and reducing glucose production in the liver, leading to better control of blood sugar levels.
Key Features:
- Active Ingredient: Semaglutide.
- Available in multiple dosages: 0.25 mg, 0.5 mg, 1 mg, and 2 mg, administered once a week.
- Subcutaneous injection: Can be injected into the abdomen, thigh, or upper arm.
- Effective for glycemic control: Helps lower blood glucose and supports weight loss.
Benefits:
- Weight loss: Helps in losing weight, especially in patients struggling with obesity.
- Improved glycemic control: Significantly reduces blood glucose levels in people with type 2 diabetes.
- Can be used alone or in combination with other medications like insulin or metformin.
OZEMPICĀ® 1mg: Indications
OZEMPICĀ® is primarily indicated for patients with type 2 diabetes mellitus who require better control of blood glucose levels. It can also be used for patients with established cardiovascular disease to reduce the risk of major cardiovascular events.
Indications:
- Type 2 diabetes: Improves blood sugar levels when used alongside diet and exercise.
- Cardiovascular risk reduction: Reduces the risk of cardiovascular events in patients with type 2 diabetes and established cardiovascular disease.
OZEMPICĀ® 1mg: Ingredients
OZEMPICĀ® contains semaglutide as its active ingredient. The formulation also includes other components to stabilize and preserve the injection.
Ingredients:
- Semaglutide (active ingredient).
- Dibasic sodium phosphate dihydrate: Buffer.
- Phenol: Preservative.
- Propylene glycol: Stabilizer.
- Water for injections: Solvent.
OZEMPICĀ® 1mg: How To Use
OZEMPICĀ® is administered once a week, at any time of day, with or without meals. It should be injected subcutaneously into the abdomen, thigh, or upper arm. The starting dose is typically 0.25 mg for the first 4 weeks, followed by 0.5 mg per week. If needed, the dose can be increased to 1 mg or 2 mg.
Instructions for Use:
- Starting Dose: 0.25 mg once weekly for the first 4 weeks.
- Increase Dose: After 4 weeks, increase to 0.5 mg, then to 1 mg if necessary.
- Injection Sites: Administer the injection into the abdomen, thigh, or upper arm, rotating sites each week.
- Missed Dose: If a dose is missed, administer it within 5 days. If more than 5 days have passed, skip the missed dose and continue the regular schedule.
OZEMPICĀ® 1mg: Side Effects
Common side effects associated with OZEMPICĀ® are primarily gastrointestinal, such as nausea, vomiting, and diarrhea. Rare but serious side effects include pancreatitis, thyroid cancer, and kidney injury.
Common Side Effects:
- Nausea: Occurs in up to 20% of patients.
- Vomiting, diarrhea, and abdominal pain are also common.
- Decreased appetite and fatigue.
Serious Side Effects:
- Pancreatitis: Severe abdominal pain with nausea and vomiting.
- Thyroid C-cell tumors: Risk of medullary thyroid carcinoma (MTC) and other thyroid issues.
- Acute kidney injury: Particularly in patients with pre-existing kidney problems.
OZEMPICĀ® 1mg: Clinical Studies
Clinical trials have shown that OZEMPICĀ® is effective in reducing HbA1c and promoting weight loss in patients with type 2 diabetes. It also has cardiovascular benefits, helping reduce the risk of heart attacks, strokes, and cardiovascular deaths.
Key Findings:
- HbA1c Reduction: Significant decrease in HbA1c levels, with a reduction of up to 1.6% in patients using 1 mg of OZEMPICĀ®.
- Weight Loss: Patients lost between 2-5 kg depending on the dosage.
- Cardiovascular Outcomes: Patients with type 2 diabetes and heart disease had a 20-30% reduction in major cardiovascular events when treated with OZEMPICĀ®.
OZEMPICĀ® 1mg: Manufacturer Information
OZEMPICĀ® is manufactured by Novo Nordisk, a leading global pharmaceutical company specializing in diabetes care. Novo Nordisk is committed to providing innovative treatments for diabetes, obesity, and other chronic conditions.
Manufacturer Details:
- Brand: OZEMPICĀ®.
- Manufacturer: Novo Nordisk.
- Headquarters: Denmark.
- Specialization: Diabetes and obesity treatment.
OZEMPICĀ® 1mg: FAQ
How often should I inject OZEMPICĀ®?
OZEMPICĀ® is injected once a week, at the same time each week. It can be administered with or without food.
Can I use OZEMPICĀ® if I have type 1 diabetes?
No, OZEMPICĀ® is not for type 1 diabetes. It is specifically for type 2 diabetes mellitus.
What should I do if I miss a dose?
If you miss a dose, administer it within 5 days. If more than 5 days have passed, skip the dose and continue with your regular schedule.
Are there any risks associated with using OZEMPICĀ®?
Yes, some serious risks include pancreatitis, thyroid tumors, and kidney injury. Gastrointestinal side effects like nausea and vomiting are also common.
Can OZEMPICĀ® be used during pregnancy? OZEMPICĀ® is not recommended during pregnancy.
If you plan to become pregnant, discontinue OZEMPICĀ® at least 2 months before pregnancy. Always consult your doctor before making changes to your medication during pregnancy.
Related products
